local_document	local_page	document_name	document_number	disease_state
2904298	3	R - Epcoritamab Frequently Asked Questions (FAQ) (v11.0)	EPCO-US-00076-FM	DLBCL
2904298	16	R - Epcoritamab Frequently Asked Questions (FAQ) (v11.0)	EPCO-US-00076-FM	DLBCL
2904298	27	R - Epcoritamab Frequently Asked Questions (FAQ) (v11.0)	EPCO-US-00076-FM	DLBCL
2904298	1	R - Epcoritamab Frequently Asked Questions (FAQ) (v11.0)	EPCO-US-00076-FM	DLBCL
5742959	17	P-Epcoritamab Dosing and Administration (v1.0)	EPCO-US-00137-FM	DLBCL, Follicular Lymphoma
5742959	18	P-Epcoritamab Dosing and Administration (v1.0)	EPCO-US-00137-FM	DLBCL, Follicular Lymphoma
5742959	28	P-Epcoritamab Dosing and Administration (v1.0)	EPCO-US-00137-FM	DLBCL, Follicular Lymphoma
5742959	21	P-Epcoritamab Dosing and Administration (v1.0)	EPCO-US-00137-FM	DLBCL, Follicular Lymphoma
5742959	31	P-Epcoritamab Dosing and Administration (v1.0)	EPCO-US-00137-FM	DLBCL, Follicular Lymphoma
5742959	3	P-Epcoritamab Dosing and Administration (v1.0)	EPCO-US-00137-FM	DLBCL, Follicular Lymphoma
5742959	20	P-Epcoritamab Dosing and Administration (v1.0)	EPCO-US-00137-FM	DLBCL, Follicular Lymphoma
3660341	69	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	55	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	76	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	75	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	23	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	26	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	38	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	35	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	45	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	40	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	25	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	64	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	67	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	65	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	80	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	82	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	79	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	88	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	2	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	92	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	85	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	81	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	89	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	84	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	86	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	90	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	83	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	6	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	91	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	78	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	39	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	41	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	37	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	27	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	24	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	22	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	18	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
3660341	4	P - M23-362 MSL STV Deck Protocol v3.0 (v2.0)	EPCO-US-00098-FM	DLBCL, Follicular Lymphoma
6162459	18	P - 37-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v1.0)	EPCO-US-00140-FM	DLBCL
6162459	17	P - 37-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v1.0)	EPCO-US-00140-FM	DLBCL
6162459	16	P - 37-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v1.0)	EPCO-US-00140-FM	DLBCL
6162459	3	P - 37-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v1.0)	EPCO-US-00140-FM	DLBCL
6162459	8	P - 37-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v1.0)	EPCO-US-00140-FM	DLBCL
6162459	4	P - 37-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v1.0)	EPCO-US-00140-FM	DLBCL
6162459	10	P - 37-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v1.0)	EPCO-US-00140-FM	DLBCL
4501696	5	P - 31-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v3.0)	EPCO-US-00120-FM	DLBCL
4501696	7	P - 31-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v3.0)	EPCO-US-00120-FM	DLBCL
4501696	16	P - 31-Month Follow-Up with Epcoritamab in 3L+ DLBCL/HGBL (v3.0)	EPCO-US-00120-FM	DLBCL
4776985	2	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	59	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	89	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	78	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	27	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	55	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	22	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	26	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	18	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	4	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	16	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	15	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	14	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	56	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	36	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	28	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	17	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	24	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	37	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	39	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	50	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	45	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	65	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	23	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	41	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	25	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	40	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	64	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4776985	35	P - M23-362 MSL STV Deck Protocol v4 (v2.0)	EPCO-US-00132-FM	DLBCL, Follicular Lymphoma
4458360	72	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	88	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	7	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	116	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	58	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	15	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	119	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	121	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	115	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	92	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	118	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	124	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	79	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	123	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	120	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	122	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	93	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	112	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	114	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	21	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	20	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	46	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	68	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	55	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	144	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	74	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	61	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	105	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	4	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	28	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	40	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	139	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	32	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	45	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	29	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	5	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	140	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	41	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	33	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	110	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	8	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	67	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	75	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	111	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4458360	2	R - ASCO/EHA Epcoritamab Priority Data Presentations (v6.0)	EPCO-US-00119-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4336109	19	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	11	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	15	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	13	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	1	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	17	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	14	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	7	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	12	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4336109	9	RZB CD SEQUENCE Data Visualization IMA (v1.0)	RISN-US-00495-FM	Crohns Disease (CD)
4016902	2	ECCO 2024 RZB-CD SEQUENCE Endoscopic Outcomes (v1.0)	RISN-US-00474-FM	Crohns Disease (CD)
4016902	6	ECCO 2024 RZB-CD SEQUENCE Endoscopic Outcomes (v1.0)	RISN-US-00474-FM	Crohns Disease (CD)
3395985	14	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	15	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	4	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	18	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	42	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	12	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	9	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	8	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	11	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	17	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
3395985	19	P_SEQUENCE MOSL (v2.0)	RISN-US-00406-FM	Crohns Disease (CD)
4016899	4	ECCO 2024 RZB-CD SEQUENCE Clinical Outcomes (v1.0)	RISN-US-00472-FM	Crohns Disease (CD)
4016899	7	ECCO 2024 RZB-CD SEQUENCE Clinical Outcomes (v1.0)	RISN-US-00472-FM	Crohns Disease (CD)
4016899	3	ECCO 2024 RZB-CD SEQUENCE Clinical Outcomes (v1.0)	RISN-US-00472-FM	Crohns Disease (CD)
3389777	7	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	19	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	12	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	10	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	9	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	11	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	3	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	5	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	6	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	8	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
3389777	28	P_RZB CD SEQUENCE Flat Deck (v2.0)	RISN-US-00404-FM	Crohns Disease (CD)
4016903	5	ECCO 2024 RZB-CD SEQUENCE Steroid Sparing Effects (v1.0)	RISN-US-00475-FM	Crohns Disease (CD)
5892612	1	UEGW 2024 RZB-CD SEQUENCE SES-CD Improvements (v1.0)	RISN-US-00570-FM	Crohns Disease (CD)
1814196	35	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	40	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	3	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	38	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	84	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	10	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	20	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	68	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	67	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	83	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	72	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	81	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	22	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	70	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	27	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	4	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	73	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	79	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	57	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	61	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	96	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	55	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	32	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	74	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	21	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	66	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	23	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	60	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	65	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	26	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1814196	53	R_RZB CD IMA_For GMI Use Only (v4.0)	RISN-US-00289-FM	Crohns Disease (CD)
1789974	9	P_SKYRIZI CD Short Clinical_MOSL (v5.0)	RISN-US-00284-FM	Crohns Disease (CD)
1789974	6	P_SKYRIZI CD Short Clinical_MOSL (v5.0)	RISN-US-00284-FM	Crohns Disease (CD)
4152845	17	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	72	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	11	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	68	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	15	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	33	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	35	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	46	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	38	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	43	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	45	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	48	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	50	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	49	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	97	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	5	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	8	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	53	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	36	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	42	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	40	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	7	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	71	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	24	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	63	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	76	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	66	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	27	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	91	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	89	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	34	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	87	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	23	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	25	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	9	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	21	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	19	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	2	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	94	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	20	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	47	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	14	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	16	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	39	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	64	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	18	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	70	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
4152845	74	P_CLL Interactive Medical Aid (IMA) (v3.0)	BCL2-US-00409-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	10	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	14	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	17	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	16	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	21	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	19	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	18	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	20	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	9	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	11	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	13	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
3535390	12	P_Diving Deep into FTD and Time Off Treatment_CLL14 APP (v3.0)	BCL2-US-00391-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	3	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	43	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	11	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	42	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	38	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	41	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	40	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	10	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	39	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	9	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	13	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	1	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	48	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	30	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	21	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	44	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	26	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	17	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	35	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	6	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	52	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	24	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	15	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	50	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	32	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	46	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	28	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	19	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	37	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	4	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	12	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	23	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	14	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	2	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	49	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	31	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	22	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	45	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	27	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	18	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	36	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	25	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	16	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	34	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	51	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	47	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	29	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	20	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	5	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	7	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	33	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
4479120	8	VENETIAN (M24-287) STV Deck 2024 (v3.0)	BCL2-US-00419-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	15	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	3	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	50	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	4	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	25	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	13	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	23	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	7	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	35	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	59	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	10	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	32	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	22	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	26	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	24	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	37	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	8	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	55	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	31	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	48	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	27	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	38	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	61	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	34	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	11	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	53	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	56	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	57	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	33	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	16	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	29	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	1	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	42	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	40	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	5	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	51	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	41	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314866	2	R_CLL14 Reactive (v3.0)	BCL2-US-00375-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	55	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	42	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	43	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	33	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	58	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	20	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	47	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	15	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	52	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	35	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	9	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	39	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	8	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	13	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	26	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	40	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	49	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	24	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	31	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	11	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	45	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	25	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	32	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	48	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	16	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	36	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	10	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	28	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	5	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	44	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	51	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	34	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	27	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	7	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	50	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	22	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	38	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	30	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	46	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	1	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	21	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	29	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	3	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	2	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	4	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	17	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	14	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3314859	19	R_Sequencing with Venetoclax in CLL (v10.0)	BCL2-US-00373-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	15	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	23	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	24	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	22	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	11	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	25	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	26	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	28	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	29	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	16	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	13	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	21	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	17	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3221347	18	P_Venetoclax CLL Scientific Value Story_MOSL (v3.0)	BCL2-US-00365-FM	Chronic Lymphocytic Leukemia (CLL)
3535304	12	P_Diving Deep into FTD and Time Off Treatment_CLL14 MD (v2.0)	BCL2-US-00390-FM	Chronic Lymphocytic Leukemia (CLL)
3535304	9	P_Diving Deep into FTD and Time Off Treatment_CLL14 MD (v2.0)	BCL2-US-00390-FM	Chronic Lymphocytic Leukemia (CLL)
3535304	10	P_Diving Deep into FTD and Time Off Treatment_CLL14 MD (v2.0)	BCL2-US-00390-FM	Chronic Lymphocytic Leukemia (CLL)
3535304	6	P_Diving Deep into FTD and Time Off Treatment_CLL14 MD (v2.0)	BCL2-US-00390-FM	Chronic Lymphocytic Leukemia (CLL)
3535304	16	P_Diving Deep into FTD and Time Off Treatment_CLL14 MD (v2.0)	BCL2-US-00390-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	4	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	2	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	39	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	19	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	18	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	11	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	5	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	41	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	38	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	12	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	14	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	13	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	9	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	3	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	17	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	35	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	26	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	44	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	31	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	22	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	40	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	29	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	20	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	37	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	15	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	33	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	24	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	42	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	6	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	28	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	36	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	27	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	45	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	32	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	23	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	30	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	21	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	16	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	34	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	8	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	7	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	43	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	1	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2245565	10	REVENG (M20-356) STV Deck 2024 (v5.0)	BCL2-US-00328-FM	Chronic Lymphocytic Leukemia (CLL)
2661343	10	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	17	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	22	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	20	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	23	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	21	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	46	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	29	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	30	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	3	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	2	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	18	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	19	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	9	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	24	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	35	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	37	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	47	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	36	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	8	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	38	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	25	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	31	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	34	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	32	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	48	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	15	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	14	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	1	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
2661343	16	P_Ven CLL and AML Clinical Overview and Dosing Deck MOSL (v2.0)	BCL2-US-00347-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
4631531	12	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	103	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	11	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	96	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	21	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	86	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	13	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	102	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	9	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	49	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	58	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	16	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	5	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	43	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
4631531	88	R - Epcoritamab Inservice Medical Deck (v2.0)	EPCO-US-00127-FM	DLBCL, Follicular Lymphoma
3183905	58	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	9	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	22	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	23	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	35	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	29	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	8	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	36	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	24	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	50	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	37	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	62	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	44	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	45	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	43	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	12	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	11	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	15	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	10	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	55	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
3183905	1	P-M20-621 MSL STV Deck (v3.0)	EPCO-US-00086-FM	DLBCL
6511652	23	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	18	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	2	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	17	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	26	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	64	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	45	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	31	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	59	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	41	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	58	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	11	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	29	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	47	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	33	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	24	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	43	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	10	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	19	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	65	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	27	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	51	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	32	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	60	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	5	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	42	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	49	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	12	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	21	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	4	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	40	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	57	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	48	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	53	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	16	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	63	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	44	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	1	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	54	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	9	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	36	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	30	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	28	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	6	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	8	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	62	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	35	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	13	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	56	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	34	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	25	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
6511652	15	M22-003 STV Deck Protocol V4 (v1.0)	EPCO-US-00142-FM	Follicular Lymphoma
4630204	2	R - CRS DLBCL Prophylaxis Pocket Guide (v2.0)	EPCO-US-00122-FM	DLBCL
4630204	1	R - CRS DLBCL Prophylaxis Pocket Guide (v2.0)	EPCO-US-00122-FM	DLBCL
2273170	1	Proactive_RZB CD OBI Real Life Handling Study (AIBD 2022) (v2.0)	RISN-US-00344-FM	Crohns Disease (CD)
559106	41	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	13	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	9	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	7	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	8	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	19	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	16	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	22	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	20	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
559106	15	P_Skyrizi Clinical and Economic Resource_MOSL (v7.0)	RISN-US-00061-FM	Crohns Disease (CD), Immunology Cross-TA, Psoriasis (Ps), Psoriatic Arthritis (PsA)
4630352	2	R - Pharmacy Manual FL (empty vial method) (v1.0)	EPCO-US-00129-FM	Follicular Lymphoma
2883041	1	R-Epcoritamab Dosing and Administration (Syringe to Syringe) Pocket Guide DLBCL/HGBL (v2.0)	EPCO-US-00071-FM	DLBCL
4433787	12	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	6	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	15	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	8	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	11	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	2	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	9	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	7	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	10	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	4	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	5	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	1	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	3	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	14	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
4433787	13	EPCORE Clinical Development Brochure (Dec 2024) (v3.0)	EPCO-US-00117-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Non-Hodgkin's Lymphoma (NHL)
3535454	19	P_Diving Deep into FTD and Time Off Treatment_MURANO MD (v2.0)	BCL2-US-00392-FM	Chronic Lymphocytic Leukemia (CLL)
3535454	5	P_Diving Deep into FTD and Time Off Treatment_MURANO MD (v2.0)	BCL2-US-00392-FM	Chronic Lymphocytic Leukemia (CLL)
3535454	15	P_Diving Deep into FTD and Time Off Treatment_MURANO MD (v2.0)	BCL2-US-00392-FM	Chronic Lymphocytic Leukemia (CLL)
3535454	14	P_Diving Deep into FTD and Time Off Treatment_MURANO MD (v2.0)	BCL2-US-00392-FM	Chronic Lymphocytic Leukemia (CLL)
3535454	6	P_Diving Deep into FTD and Time Off Treatment_MURANO MD (v2.0)	BCL2-US-00392-FM	Chronic Lymphocytic Leukemia (CLL)
3535454	9	P_Diving Deep into FTD and Time Off Treatment_MURANO MD (v2.0)	BCL2-US-00392-FM	Chronic Lymphocytic Leukemia (CLL)
3535454	10	P_Diving Deep into FTD and Time Off Treatment_MURANO MD (v2.0)	BCL2-US-00392-FM	Chronic Lymphocytic Leukemia (CLL)
3535454	13	P_Diving Deep into FTD and Time Off Treatment_MURANO MD (v2.0)	BCL2-US-00392-FM	Chronic Lymphocytic Leukemia (CLL)
476081	3	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	2	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	10	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	6	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	25	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	24	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	9	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	8	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	12	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	11	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	14	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	7	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	26	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	15	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	20	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	5	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	4	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
476081	21	P_CLL and AML Dosing Guide (v10.0)	BCL2-US-00139-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
3314863	5	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	99	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	108	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	95	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	112	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	109	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	93	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	56	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	39	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	73	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	24	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	30	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	84	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	18	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	71	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	41	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	111	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	60	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	105	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	54	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	75	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	66	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	26	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	70	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	110	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	97	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	78	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	104	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	53	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	74	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	65	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	25	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	72	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	61	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	55	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	58	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	76	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	67	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	102	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	63	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	1	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	16	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	92	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	29	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	103	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	86	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	45	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	40	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	80	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	83	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	43	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	88	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	12	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	21	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	14	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	79	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	98	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	31	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	59	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	87	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	101	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	107	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	46	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	85	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	81	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	3	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	100	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	2	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	94	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	28	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	4	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	96	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	68	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	33	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	50	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	13	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	34	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	57	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	91	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	62	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	19	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	8	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	9	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	10	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	7	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	51	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	90	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	44	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	52	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	11	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	49	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	38	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	22	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	37	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	23	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3314863	36	R_MURANO Reactive (v1.0)	BCL2-US-00374-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	25	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	5	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	16	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	18	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	15	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	17	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	19	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	21	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	13	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	12	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	10	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	6	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
3535552	9	P_Diving Deep into FTD and Time Off Treatment_MURANO APP (v3.0)	BCL2-US-00393-FM	Chronic Lymphocytic Leukemia (CLL)
6440906	2	R_Reduced Ven Dosing and Ven Discontinuation FAQ (v1.0)	BCL2-US-00442-FM	Acute Myeloid Leukemia (AML)
3358513	34	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	43	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	16	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	21	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	19	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	18	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	37	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	17	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	39	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	33	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	9	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	36	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	10	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3358513	20	P_Diving Deep into FTD and Time Off Treatment_Full APP (v5.0)	BCL2-US-00381-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	4	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	7	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	43	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	45	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	15	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	14	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	23	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	10	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	35	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	19	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	5	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	17	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	47	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	27	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	37	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	39	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	31	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	12	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	51	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	21	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	6	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	41	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	26	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	16	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	33	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	11	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	20	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	36	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	9	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	18	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	38	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	32	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	13	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	52	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	22	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	8	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	44	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	42	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	1	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	24	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	29	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	25	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	46	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	34	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	30	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	48	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	28	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	3	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
3314891	2	R_RWE Library for Venetoclax in CLL (v5.0)	BCL2-US-00376-FM	Chronic Lymphocytic Leukemia (CLL)
842290	33	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	129	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	162	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	79	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	85	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	130	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	118	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	32	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	119	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	109	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	152	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	100	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	95	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	135	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	153	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	52	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	8	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	41	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	127	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	133	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	167	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	67	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	57	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	105	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	144	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	14	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	53	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	69	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	126	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	9	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	15	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	84	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	72	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	103	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	120	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	128	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	91	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	34	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	59	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	78	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	112	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	107	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	29	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	110	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	25	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	75	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	35	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	165	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	122	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	43	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	154	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	164	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	58	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	113	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	55	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	61	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	27	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	111	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	49	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	3	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	30	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	2	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	132	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	51	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	4	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	141	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	94	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	66	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	82	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	90	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	115	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	174	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	89	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	104	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	44	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	146	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	48	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	24	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	70	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	47	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	46	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	50	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	102	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	12	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	17	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	54	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	92	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	96	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	13	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	63	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	7	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	71	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	147	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	161	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	20	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	145	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	116	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	148	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	163	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	19	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	83	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	65	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	108	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	88	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	170	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	93	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	45	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	158	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	169	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	171	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	168	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	87	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	173	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	106	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	28	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	38	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	62	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	86	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	97	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	18	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	124	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	81	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	143	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	56	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	114	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	123	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	139	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	31	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	157	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	101	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	40	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	11	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	117	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	134	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	37	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	73	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	64	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	172	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	159	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	150	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	60	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	121	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	125	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	42	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	76	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	98	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	140	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	21	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	68	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	149	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	23	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	5	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	74	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	138	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	156	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	136	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	26	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	155	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	142	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	16	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	160	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	151	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	77	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
842290	80	R_VIALE-A  FAQ (v13.0)	BCL2-US-00219-FM	Acute Myeloid Leukemia (AML)
1520261	12	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	13	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	11	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	5	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	2	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	4	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	14	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	36	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	6	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	15	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	32	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	66	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	18	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	21	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	59	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	3	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	22	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	40	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	53	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	60	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	9	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	27	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	41	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	30	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	39	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	38	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	67	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	26	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	49	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	10	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	29	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	20	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	37	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	28	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	51	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	71	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	31	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	16	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	35	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	8	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	69	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	45	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	25	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	68	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	47	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	55	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	46	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	1	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	43	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	19	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	48	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
1520261	44	P_VIALE-T (M19-063) Protocol Overview (v6.0)	BCL2-US-00282-FM	Acute Myeloid Leukemia (AML)
753356	41	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	106	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	48	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	50	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	46	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	148	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	44	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	137	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	43	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	49	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	51	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	146	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	40	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	39	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	47	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	147	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	42	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	45	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	52	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	3	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	6	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	150	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	155	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	152	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	153	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	157	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	151	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	156	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	154	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	158	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	149	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	130	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	4	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	5	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	16	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	56	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	61	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	118	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	93	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
753356	94	R_Venetoclax MA MDS Reactive Library (v14.0)	BCL2-US-00199-FM	Acute Myeloid Leukemia (AML)
6337931	14	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	10	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	2	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	25	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	15	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	5	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	4	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	3	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	16	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	11	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	18	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6337931	22	R-ASH 2024_Ven-383-Post-Con Summaries_2024 (v1.0)	BCMA-US-00042-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM)
6479368	10	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	5	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	7	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	45	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	54	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	41	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	9	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	76	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	55	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	19	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	18	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	49	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	16	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	50	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
6479368	6	R_ASH 2024 US V+X Studies (v1.0)	BCL2-US-00444-FM	Acute Myeloid Leukemia (AML)
4626613	12	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	2	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	31	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	28	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	34	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	3	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	26	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	11	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	15	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	4	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	13	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	14	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	21	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	5	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	32	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	22	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
4626613	24	R_ASCO-EHA 2024 MSL Reactive_ABBV Summaries_AML, MDS, CLL, MCL, MM, MF, Solids (v1.0)	BCMA-US-00033-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Myelofibrosis, Solid Tumor
576475	2	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	9	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	20	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	18	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	13	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	24	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	4	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	12	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	26	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	10	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	25	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	5	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	6	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	17	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	19	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	1	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	3	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	16	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	32	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	28	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	23	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	7	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	30	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	29	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	33	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	11	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	27	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	15	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	31	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
576475	8	P_AML Disease State Deck (v11.0)	BCL2-US-00167-FM	Acute Myeloid Leukemia (AML)
6484230	1	R_Timing of Response with VEN+HMA (v1.0)	BCL2-US-00445-FM	Acute Myeloid Leukemia (AML)
6484230	5	R_Timing of Response with VEN+HMA (v1.0)	BCL2-US-00445-FM	Acute Myeloid Leukemia (AML)
6484230	4	R_Timing of Response with VEN+HMA (v1.0)	BCL2-US-00445-FM	Acute Myeloid Leukemia (AML)
6484230	3	R_Timing of Response with VEN+HMA (v1.0)	BCL2-US-00445-FM	Acute Myeloid Leukemia (AML)
6484230	2	R_Timing of Response with VEN+HMA (v1.0)	BCL2-US-00445-FM	Acute Myeloid Leukemia (AML)
2776576	14	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	2	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	11	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	8	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	10	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	3	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	9	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	6	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	5	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	7	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	1	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
2776576	4	P_VialeT (M19-063) Part One Data Updates 2023 For Investigators Only (v1.0)	BCL2-US-00353-FM	Acute Myeloid Leukemia (AML)
981258	1	Indication and Safety Overview Slides (AML) Nov 2020 (v3.0)	BCL2-US-00251-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
1544780	4	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	44	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	2	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	5	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	30	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	31	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	10	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	28	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	23	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	11	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	37	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	16	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	46	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	13	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	19	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	17	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	25	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	3	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	33	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	52	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	50	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	1	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	32	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
1544780	21	R_VIALE-T (M19-063) FAQ (v5.0)	BCL2-US-00285-FM	Acute Myeloid Leukemia (AML)
2828488	2	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	14	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	11	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	9	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	6	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	5	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	7	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	8	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	10	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	4	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	3	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
2828488	1	R_Viale T (M 19-063) Part One Data Updates 2023 (v1.0)	BCL2-US-00355-FM	Acute Myeloid Leukemia (AML)
4598030	2	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	3	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	13	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	1	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	5	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	14	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	8	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	10	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	16	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	12	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	9	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	7	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	15	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	6	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
4598030	4	P_Outpatient Short Story Deck (v1.0)	BCL2-US-00422-FM	Acute Myeloid Leukemia (AML)
3432272	3	P_Venetoclax Dosing and Dispensing Guide (v4.0)	BCL2-US-00386-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
3432272	4	P_Venetoclax Dosing and Dispensing Guide (v4.0)	BCL2-US-00386-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
3432272	2	P_Venetoclax Dosing and Dispensing Guide (v4.0)	BCL2-US-00386-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
3432272	8	P_Venetoclax Dosing and Dispensing Guide (v4.0)	BCL2-US-00386-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
3432272	9	P_Venetoclax Dosing and Dispensing Guide (v4.0)	BCL2-US-00386-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
3432272	1	P_Venetoclax Dosing and Dispensing Guide (v4.0)	BCL2-US-00386-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
1649811	46	P_Raising Awareness of Diseases in the Workforce_FINAL APPROVED_05-02-23 (v2.0)	ABBV-US-00631-FM	Acute Treatment of Migraine, Atopic Dermatitis (AD), Bipolar Disorder, Chronic Migraine (CM), Crohns Disease (CD), Disease-state (US CRM), Endometriosis, Episodic Migraine, Fibroids, Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Migraine, No Disease State, Prevention of Migraine, Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
1649811	33	P_Raising Awareness of Diseases in the Workforce_FINAL APPROVED_05-02-23 (v2.0)	ABBV-US-00631-FM	Acute Treatment of Migraine, Atopic Dermatitis (AD), Bipolar Disorder, Chronic Migraine (CM), Crohns Disease (CD), Disease-state (US CRM), Endometriosis, Episodic Migraine, Fibroids, Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Migraine, No Disease State, Prevention of Migraine, Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
1649811	34	P_Raising Awareness of Diseases in the Workforce_FINAL APPROVED_05-02-23 (v2.0)	ABBV-US-00631-FM	Acute Treatment of Migraine, Atopic Dermatitis (AD), Bipolar Disorder, Chronic Migraine (CM), Crohns Disease (CD), Disease-state (US CRM), Endometriosis, Episodic Migraine, Fibroids, Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Migraine, No Disease State, Prevention of Migraine, Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
1649811	19	P_Raising Awareness of Diseases in the Workforce_FINAL APPROVED_05-02-23 (v2.0)	ABBV-US-00631-FM	Acute Treatment of Migraine, Atopic Dermatitis (AD), Bipolar Disorder, Chronic Migraine (CM), Crohns Disease (CD), Disease-state (US CRM), Endometriosis, Episodic Migraine, Fibroids, Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Migraine, No Disease State, Prevention of Migraine, Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
1649811	50	P_Raising Awareness of Diseases in the Workforce_FINAL APPROVED_05-02-23 (v2.0)	ABBV-US-00631-FM	Acute Treatment of Migraine, Atopic Dermatitis (AD), Bipolar Disorder, Chronic Migraine (CM), Crohns Disease (CD), Disease-state (US CRM), Endometriosis, Episodic Migraine, Fibroids, Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Migraine, No Disease State, Prevention of Migraine, Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
1649811	49	P_Raising Awareness of Diseases in the Workforce_FINAL APPROVED_05-02-23 (v2.0)	ABBV-US-00631-FM	Acute Treatment of Migraine, Atopic Dermatitis (AD), Bipolar Disorder, Chronic Migraine (CM), Crohns Disease (CD), Disease-state (US CRM), Endometriosis, Episodic Migraine, Fibroids, Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Migraine, No Disease State, Prevention of Migraine, Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
1649811	48	P_Raising Awareness of Diseases in the Workforce_FINAL APPROVED_05-02-23 (v2.0)	ABBV-US-00631-FM	Acute Treatment of Migraine, Atopic Dermatitis (AD), Bipolar Disorder, Chronic Migraine (CM), Crohns Disease (CD), Disease-state (US CRM), Endometriosis, Episodic Migraine, Fibroids, Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Migraine, No Disease State, Prevention of Migraine, Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
5977335	3	P_Risankizumab Molecular Overview and CD64 Poster Summaries (v1.0)	RISN-US-00576-FM	Crohns Disease (CD)
4122246	1	P_M24-287_Ven_Initiation_Study_Fact_Sheet_for potential PIs (v3.0)	BCL2-US-00407-FM	Chronic Lymphocytic Leukemia (CLL)
4598039	3	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	2	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	288	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	4	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	39	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	192	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	305	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	322	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	274	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
4598039	126	2024 EHA Congress Compendia (v1.0)	BCMA-US-00031-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL)
6206164	3	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	2	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	361	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	31	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	147	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	314	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	397	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	146	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	32	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	5	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
6206164	1	2024 ASH Congress Compendia (v1.0)	B453-US-00003-FM	Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS)
4517164	129	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
4517164	2	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
4517164	3	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
4517164	36	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
4517164	4	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
4517164	84	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
4517164	18	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
4517164	68	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
4517164	1	ASCO 2024 Hematology Compendium (v1.0)	BCMA-US-00028-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (MM)
629571	20	P_CLL Disease State (v5.0)	BCL2-US-00176-FM	Chronic Lymphocytic Leukemia (CLL)
629571	9	P_CLL Disease State (v5.0)	BCL2-US-00176-FM	Chronic Lymphocytic Leukemia (CLL)
629571	37	P_CLL Disease State (v5.0)	BCL2-US-00176-FM	Chronic Lymphocytic Leukemia (CLL)
629571	38	P_CLL Disease State (v5.0)	BCL2-US-00176-FM	Chronic Lymphocytic Leukemia (CLL)
629571	35	P_CLL Disease State (v5.0)	BCL2-US-00176-FM	Chronic Lymphocytic Leukemia (CLL)
629571	36	P_CLL Disease State (v5.0)	BCL2-US-00176-FM	Chronic Lymphocytic Leukemia (CLL)
629571	23	P_CLL Disease State (v5.0)	BCL2-US-00176-FM	Chronic Lymphocytic Leukemia (CLL)
629571	10	P_CLL Disease State (v5.0)	BCL2-US-00176-FM	Chronic Lymphocytic Leukemia (CLL)
3297259	2	R_Venetoclax Medicaid Clinical Summary_MOSL (v1.0)	BCL2-US-00372-FM	Chronic Lymphocytic Leukemia (CLL)
2883043	2	R-Epcoritamab Pharmacy Manual DLBCL/HGBL (Syringe to Syringe) (v1.0)	EPCO-US-00073-FM	DLBCL
5767991	3	R_GLOW Phase 3 Study (v1.0)	BCL2-US-00432-FM	Chronic Lymphocytic Leukemia (CLL)
5767991	2	R_GLOW Phase 3 Study (v1.0)	BCL2-US-00432-FM	Chronic Lymphocytic Leukemia (CLL)
5767991	4	R_GLOW Phase 3 Study (v1.0)	BCL2-US-00432-FM	Chronic Lymphocytic Leukemia (CLL)
5767991	6	R_GLOW Phase 3 Study (v1.0)	BCL2-US-00432-FM	Chronic Lymphocytic Leukemia (CLL)
5767991	10	R_GLOW Phase 3 Study (v1.0)	BCL2-US-00432-FM	Chronic Lymphocytic Leukemia (CLL)
5767991	1	R_GLOW Phase 3 Study (v1.0)	BCL2-US-00432-FM	Chronic Lymphocytic Leukemia (CLL)
2370229	1	P_M20-356 (ReVenG) Study Fact Sheet - For Potential Investigators and TAP (v6.0)	BCL2-US-00334-FM	Chronic Lymphocytic Leukemia (CLL)
5745791	3	R_RZB UC and CD Experimental Dosing (v1.0)	RISN-US-00556-FM	Crohns Disease (CD), Ulcerative Colitis (UC)
5745791	17	R_RZB UC and CD Experimental Dosing (v1.0)	RISN-US-00556-FM	Crohns Disease (CD), Ulcerative Colitis (UC)
5745791	15	R_RZB UC and CD Experimental Dosing (v1.0)	RISN-US-00556-FM	Crohns Disease (CD), Ulcerative Colitis (UC)
5745791	20	R_RZB UC and CD Experimental Dosing (v1.0)	RISN-US-00556-FM	Crohns Disease (CD), Ulcerative Colitis (UC)
4673564	12	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	1	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	30	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	2	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	8	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	34	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	18	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	17	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	4	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	5	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	7	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	19	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	25	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	11	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	31	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4673564	10	R - Follicular Lymphoma Manuscript Slide Deck - Linton Lancet Haematol 2024 (v2.0)	EPCO-US-00130-FM	Follicular Lymphoma
4631720	22	P - Epcoritamab in 3L+ Follicular Lymphoma (v4.0)	EPCO-US-00126-FM	Follicular Lymphoma
4631720	9	P - Epcoritamab in 3L+ Follicular Lymphoma (v4.0)	EPCO-US-00126-FM	Follicular Lymphoma
4631720	5	P - Epcoritamab in 3L+ Follicular Lymphoma (v4.0)	EPCO-US-00126-FM	Follicular Lymphoma
4631720	7	P - Epcoritamab in 3L+ Follicular Lymphoma (v4.0)	EPCO-US-00126-FM	Follicular Lymphoma
4631720	8	P - Epcoritamab in 3L+ Follicular Lymphoma (v4.0)	EPCO-US-00126-FM	Follicular Lymphoma
4631720	2	P - Epcoritamab in 3L+ Follicular Lymphoma (v4.0)	EPCO-US-00126-FM	Follicular Lymphoma
4631720	6	P - Epcoritamab in 3L+ Follicular Lymphoma (v4.0)	EPCO-US-00126-FM	Follicular Lymphoma
4631720	4	P - Epcoritamab in 3L+ Follicular Lymphoma (v4.0)	EPCO-US-00126-FM	Follicular Lymphoma
2875563	16	Epcoritamab US Prescribing Information - P (v3.0)	EPCO-US-00064-FM	DLBCL, Follicular Lymphoma
2875563	45	Epcoritamab US Prescribing Information - P (v3.0)	EPCO-US-00064-FM	DLBCL, Follicular Lymphoma
3765913	18	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	1	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	45	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	47	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	36	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	15	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	23	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	20	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	40	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	26	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	24	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	30	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	31	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	8	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	9	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	22	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	49	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	48	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	28	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	13	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	50	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	21	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	37	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	11	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
3765913	39	P-M22-003 STV Deck v2.0 (v2.0)	EPCO-US-00106-FM	Follicular Lymphoma
4583117	2	P_Venetoclax Dosing Leave Behind_CLL (v1.0)	BCL2-US-00421-FM	Chronic Lymphocytic Leukemia (CLL)
4583117	3	P_Venetoclax Dosing Leave Behind_CLL (v1.0)	BCL2-US-00421-FM	Chronic Lymphocytic Leukemia (CLL)
4583117	1	P_Venetoclax Dosing Leave Behind_CLL (v1.0)	BCL2-US-00421-FM	Chronic Lymphocytic Leukemia (CLL)
3509122	2	P_CLL Journal Club Deck (v1.0)	BCL2-US-00389-FM	Chronic Lymphocytic Leukemia (CLL)
3671724	2	AML/CLL_Dosing and Dispensing Guide_LeaveBehind (v3.0)	BCL2-US-00399-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
3671724	1	AML/CLL_Dosing and Dispensing Guide_LeaveBehind (v3.0)	BCL2-US-00399-FM	Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL)
5662214	4	P_RZB CD SC M23-784 STV_For Investigators Only (v1.0)	RISN-US-00546-FM	Crohns Disease (CD)
5662214	16	P_RZB CD SC M23-784 STV_For Investigators Only (v1.0)	RISN-US-00546-FM	Crohns Disease (CD)
5662214	3	P_RZB CD SC M23-784 STV_For Investigators Only (v1.0)	RISN-US-00546-FM	Crohns Disease (CD)
5662214	5	P_RZB CD SC M23-784 STV_For Investigators Only (v1.0)	RISN-US-00546-FM	Crohns Disease (CD)
5662214	13	P_RZB CD SC M23-784 STV_For Investigators Only (v1.0)	RISN-US-00546-FM	Crohns Disease (CD)
2939222	91	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	62	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	28	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	119	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	71	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	9	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	39	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	45	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	70	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	50	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	95	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	44	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	66	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	33	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	68	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	40	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	51	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	11	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	128	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	10	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	46	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	41	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	36	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	67	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	38	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	97	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	12	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	4	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2939222	30	R_UPA CD IMA_For GMI Use Only (v2.0)	JAKa-US-00634-FM	Crohns Disease (CD)
2883425	5	ECCO23_UPA CD Rapid Response (v1.0)	JAKa-US-00600-FM	Crohns Disease (CD)
2883425	6	ECCO23_UPA CD Rapid Response (v1.0)	JAKa-US-00600-FM	Crohns Disease (CD)
2883425	4	ECCO23_UPA CD Rapid Response (v1.0)	JAKa-US-00600-FM	Crohns Disease (CD)
2883426	8	ECCO23_UPA-CD Prior Biologics Failed (v1.0)	JAKa-US-00601-FM	Crohns Disease (CD)
2883426	4	ECCO23_UPA-CD Prior Biologics Failed (v1.0)	JAKa-US-00601-FM	Crohns Disease (CD)
2883426	10	ECCO23_UPA-CD Prior Biologics Failed (v1.0)	JAKa-US-00601-FM	Crohns Disease (CD)
2883426	9	ECCO23_UPA-CD Prior Biologics Failed (v1.0)	JAKa-US-00601-FM	Crohns Disease (CD)
1629593	2	P_UPA RA, PsA, AD,UC, AS, nr-axSpA, and CD Medical Indications and Important Safety Considerations (v6.0)	JAKa-US-00437-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
1681289	79	R_Skyrizi Reactive Deck MOSL (v5.0)	RISN-US-00262-FM	Crohns Disease (CD), Psoriasis (Ps), Psoriatic Arthritis (PsA)
1681289	56	R_Skyrizi Reactive Deck MOSL (v5.0)	RISN-US-00262-FM	Crohns Disease (CD), Psoriasis (Ps), Psoriatic Arthritis (PsA)
1681289	86	R_Skyrizi Reactive Deck MOSL (v5.0)	RISN-US-00262-FM	Crohns Disease (CD), Psoriasis (Ps), Psoriatic Arthritis (PsA)
1681289	114	R_Skyrizi Reactive Deck MOSL (v5.0)	RISN-US-00262-FM	Crohns Disease (CD), Psoriasis (Ps), Psoriatic Arthritis (PsA)
1681289	95	R_Skyrizi Reactive Deck MOSL (v5.0)	RISN-US-00262-FM	Crohns Disease (CD), Psoriasis (Ps), Psoriatic Arthritis (PsA)
1681289	115	R_Skyrizi Reactive Deck MOSL (v5.0)	RISN-US-00262-FM	Crohns Disease (CD), Psoriasis (Ps), Psoriatic Arthritis (PsA)
1681289	18	R_Skyrizi Reactive Deck MOSL (v5.0)	RISN-US-00262-FM	Crohns Disease (CD), Psoriasis (Ps), Psoriatic Arthritis (PsA)
1681289	14	R_Skyrizi Reactive Deck MOSL (v5.0)	RISN-US-00262-FM	Crohns Disease (CD), Psoriasis (Ps), Psoriatic Arthritis (PsA)
2046316	10	UEGW_RZB-CD # Prior Failed Biologics (v2.0)	RISN-US-00319-FM	Crohns Disease (CD)
2046316	3	UEGW_RZB-CD # Prior Failed Biologics (v2.0)	RISN-US-00319-FM	Crohns Disease (CD)
6478358	6	R_NCCN Update 1.2025 FAQ (v1.0)	BCL2-US-00443-FM	Acute Myeloid Leukemia (AML)
4016900	4	ECCO 2024 RZB-CD SEQUENCE Disease Location (v1.0)	RISN-US-00473-FM	Crohns Disease (CD)
4016900	8	ECCO 2024 RZB-CD SEQUENCE Disease Location (v1.0)	RISN-US-00473-FM	Crohns Disease (CD)
2883039	1	R - ICANS Management Pocket Guide (v2.0)	EPCO-US-00069-FM	DLBCL
2883038	1	CRS Management Pocket Guide - R (v3.0)	EPCO-US-00068-FM	DLBCL
4631714	1	R - Dosing & Administration FL Pocket Guide (Empty Vial Dilution Method) (v2.0)	EPCO-US-00125-FM	Follicular Lymphoma
4839734	4	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	7	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	12	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	3	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	10	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	9	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	5	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	8	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	13	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	11	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	1	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4839734	6	P - NHL-2 Epcor+RCHOP ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00134-FM	DLBCL
4627780	1	R - Epcoritamab FL CRS Prophylaxis Pocket Guide (v2.0)	EPCO-US-00123-FM	Follicular Lymphoma
4627780	2	R - Epcoritamab FL CRS Prophylaxis Pocket Guide (v2.0)	EPCO-US-00123-FM	Follicular Lymphoma
4745604	1	AIBD_2023_UPA-CD_Number_of_Surgeries_Pst7 (v1.0)	JAKa-US-00737-FM	Crohns Disease (CD)
2883424	7	ECCO23_UPA-CD Steroid-free Endpoints (v1.0)	JAKa-US-00599-FM	Crohns Disease (CD)
2883424	5	ECCO23_UPA-CD Steroid-free Endpoints (v1.0)	JAKa-US-00599-FM	Crohns Disease (CD)
2883424	6	ECCO23_UPA-CD Steroid-free Endpoints (v1.0)	JAKa-US-00599-FM	Crohns Disease (CD)
2883424	4	ECCO23_UPA-CD Steroid-free Endpoints (v1.0)	JAKa-US-00599-FM	Crohns Disease (CD)
3386915	7	P_Venetoclax CLL MOSL TCC BIM VA Summary (v3.0)	BCL2-US-00383-FM	Chronic Lymphocytic Leukemia (CLL)
4630325	2	R - Pharmacy Manual FL (Syringe Dilution Method) (v1.0)	EPCO-US-00124-FM	Follicular Lymphoma
2827556	4	P-UPA Cross Indication Safety IMA Module (v2.0)	JAKa-US-00565-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
2827556	2	P-UPA Cross Indication Safety IMA Module (v2.0)	JAKa-US-00565-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Ulcerative Colitis (UC)
2883037	37	R - Epcoritamab Frequently Asked Questions (v5.0)	EPCO-US-00067-FM	DLBCL
2883037	48	R - Epcoritamab Frequently Asked Questions (v5.0)	EPCO-US-00067-FM	DLBCL
2883037	1	R - Epcoritamab Frequently Asked Questions (v5.0)	EPCO-US-00067-FM	DLBCL
2883037	39	R - Epcoritamab Frequently Asked Questions (v5.0)	EPCO-US-00067-FM	DLBCL
3533649	3	UEGW 2023_UPA-CD Early Responder Outcomes (v1.0)	JAKa-US-00667-FM	Crohns Disease (CD)
3533649	6	UEGW 2023_UPA-CD Early Responder Outcomes (v1.0)	JAKa-US-00667-FM	Crohns Disease (CD)
3533649	2	UEGW 2023_UPA-CD Early Responder Outcomes (v1.0)	JAKa-US-00667-FM	Crohns Disease (CD)
3533754	1	UEGW 2023_UPA-CD EIMs (v1.0)	JAKa-US-00670-FM	Crohns Disease (CD)
2883423	9	ECCO23_UPA CD Endo Outcomes (v1.0)	JAKa-US-00598-FM	Crohns Disease (CD)
2883423	4	ECCO23_UPA CD Endo Outcomes (v1.0)	JAKa-US-00598-FM	Crohns Disease (CD)
2883423	5	ECCO23_UPA CD Endo Outcomes (v1.0)	JAKa-US-00598-FM	Crohns Disease (CD)
2883423	3	ECCO23_UPA CD Endo Outcomes (v1.0)	JAKa-US-00598-FM	Crohns Disease (CD)
3533636	11	UEGW 2023_UPA-CD Durability (v1.0)	JAKa-US-00666-FM	Crohns Disease (CD)
3533636	5	UEGW 2023_UPA-CD Durability (v1.0)	JAKa-US-00666-FM	Crohns Disease (CD)
3533636	10	UEGW 2023_UPA-CD Durability (v1.0)	JAKa-US-00666-FM	Crohns Disease (CD)
3533636	8	UEGW 2023_UPA-CD Durability (v1.0)	JAKa-US-00666-FM	Crohns Disease (CD)
3533636	7	UEGW 2023_UPA-CD Durability (v1.0)	JAKa-US-00666-FM	Crohns Disease (CD)
3593862	14	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	2	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	19	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	18	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	27	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	32	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	23	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	5	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	30	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	21	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	3	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	16	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	34	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	25	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	7	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	11	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	20	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	33	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	28	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	31	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	22	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	4	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	17	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	35	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	26	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
3593862	9	P_Future of Immunology (v2.0)	ABBV-US-01035-FM	Ankylosing Spondylitis (AS), Atopic Dermatitis (AD), Crohns Disease (CD), Immunology Cross-TA, Inflammatory Bowel Disease (IBD), Non-radiographic Axial Spondyloarthropathy (nrAxSpA), Pediatric Crohn Disease (Ped CD), Pediatric Psoriasis (Ped Ps), Pediatric Ulcerative Colitis (Ped UC), Psoriasis (Ps), Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), Ulcerative Colitis (UC)
1734068	17	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	1	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	39	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	41	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	33	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	35	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	37	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	22	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	36	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	20	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	31	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	16	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	21	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	24	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	18	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	19	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	23	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	34	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	40	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	29	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	26	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	15	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	25	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	30	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	8	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
1734068	4	REACTIVE_RZB CD IMA (v2.0)	RISN-US-00268-FM	Crohns Disease (CD)
5983597	3	UEGW_RZB-CD ITT1C Delayed Responders (v1.0)	RISN-US-00577-FM	Crohns Disease (CD)
1701274	2	P_RZB CD Clinical Trial Overview Four-Pager (v1.0)	RISN-US-00264-FM	Crohns Disease (CD)
4354070	3	DDW24_RZB-CD SEQUENCE Biologic Remission_OP763 (v1.0)	RISN-US-00503-FM	Crohns Disease (CD)
4354070	5	DDW24_RZB-CD SEQUENCE Biologic Remission_OP763 (v1.0)	RISN-US-00503-FM	Crohns Disease (CD)
4354070	6	DDW24_RZB-CD SEQUENCE Biologic Remission_OP763 (v1.0)	RISN-US-00503-FM	Crohns Disease (CD)
2537803	1	ECCO 2023_RZB-CD Clinical Response Over 24 Weeks (v1.0)	RISN-US-00355-FM	Crohns Disease (CD)
4351915	5	R_RISE-CD M16-194 Clinical Trial Overview (v1.0)	RISN-US-00502-FM	Crohns Disease (CD)
4016906	9	ECCO 2024 UPA-CD U-ENDURE LTE (v1.0)	JAKa-US-00704-FM	Crohns Disease (CD)
4016906	4	ECCO 2024 UPA-CD U-ENDURE LTE (v1.0)	JAKa-US-00704-FM	Crohns Disease (CD)
4016906	11	ECCO 2024 UPA-CD U-ENDURE LTE (v1.0)	JAKa-US-00704-FM	Crohns Disease (CD)
4016906	5	ECCO 2024 UPA-CD U-ENDURE LTE (v1.0)	JAKa-US-00704-FM	Crohns Disease (CD)
4016906	7	ECCO 2024 UPA-CD U-ENDURE LTE (v1.0)	JAKa-US-00704-FM	Crohns Disease (CD)
4016914	4	ECCO 2024 UPA-CD Improvements in SES-CD (v1.0)	JAKa-US-00706-FM	Crohns Disease (CD)
3451650	4	ReVenG (M20-356) Pub Visual (v2.0)	BCL2-US-00387-FM	Chronic Lymphocytic Leukemia (CLL)
4839816	13	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	15	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	7	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	19	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	10	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	16	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	8	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	11	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	5	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	4	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	18	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	9	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	14	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	12	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	3	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	17	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	6	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
4839816	1	P - NHL-2 Epcor+R2 ASCO 2023 Poster Presentation - Research Support Tool (v1.0)	EPCO-US-00135-FM	Follicular Lymphoma
5997109	12	R - ASH 2024 Epcoritamab Key Highlights One-Sliders (v2.0)	EPCO-US-00138-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma
5997109	13	R - ASH 2024 Epcoritamab Key Highlights One-Sliders (v2.0)	EPCO-US-00138-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma
5997109	6	R - ASH 2024 Epcoritamab Key Highlights One-Sliders (v2.0)	EPCO-US-00138-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma
5997109	5	R - ASH 2024 Epcoritamab Key Highlights One-Sliders (v2.0)	EPCO-US-00138-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma
4722758	5	R - MSL Talking Points on Epcoritamab Costs, Economics, & Operationalization (v1.0)	EPCO-US-00131-FM	DLBCL, Follicular Lymphoma
6429290	3	P_M20-638 and M22-003 research support tool (NHL2 arm2) (v1.0)	EPCO-US-00141-FM	Follicular Lymphoma
6429290	1	P_M20-638 and M22-003 research support tool (NHL2 arm2) (v1.0)	EPCO-US-00141-FM	Follicular Lymphoma
6429290	15	P_M20-638 and M22-003 research support tool (NHL2 arm2) (v1.0)	EPCO-US-00141-FM	Follicular Lymphoma
6429290	4	P_M20-638 and M22-003 research support tool (NHL2 arm2) (v1.0)	EPCO-US-00141-FM	Follicular Lymphoma
6105892	10	ASH 2024 Epcoritamab Reactive FAQs (v1.0)	EPCO-US-00139-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma
6105892	13	ASH 2024 Epcoritamab Reactive FAQs (v1.0)	EPCO-US-00139-FM	Chronic Lymphocytic Leukemia (CLL), DLBCL, Follicular Lymphoma
